demonstrated in the Copenhagen General Population Study that elevated ApoB levels were superior to low-density lipoprotein cholesterol (LDL-C) in predicting the risk of atherosclerotic cardiovascular disease (ASCVD) (61). This evidence concerns the gene APOB and atherosclerosis.